Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
View Older Stories View More Recent Stories
-
UPDATE: Maxim Group Starts xG Technology, Inc. (XGTI) at Buy
-
Abeona Therapeutics (ABEO) PT Raised to $17 at Maxim Group
-
StreetInsider Premium Hot Research Notes Recap 7/18
-
Maxim Group Upgrades Chipotle Mexican Grill (CMG) to Buy
-
ImmunoCellular Therapeutics (IMUC) Prices Offering of Convertible Preferred Stock and Warrants
-
ImmunoCellular Therapeutics Announces Pricing of Public Offering of Convertible Preferred Stock and Warrants
-
First Republic Bank (FRC) PT Raised to $110 at Maxim Group
-
Trovagene (TROV) Reports $7.1M Direct Offering of Common Stock, Warrants
-
Trovagene Announces $7.1 Million Registered Direct Offering
-
MYnd Analytics Announces Uplisting to NASDAQ and Pricing of $8.79M Underwritten Offering
-
Maxim Group Maintains Sell on National Beverage (FIZZ) Despite 'In-Line' Results
-
Maxim Group Downgrades Kite Pharma (KITE) to Hold
-
UPDATE: Maxim Group Upgrades Hain Celestial (HAIN) to Buy
-
Cutera (CUTR) PT Raised to $33 at Maxim Group
-
Maxim Group Starts Bio-Key International (BKYI) at Buy
-
PlacementTracker Publishes First Half 2017 PIPE Market League Tables
-
Maxim Group Starts Elevate Credit Inc (ELVT) at Buy
-
Maxim Group Starts Enova International (ENVA) at Buy
-
NXT-ID (NXTD) Announces $3.43M Registered Direct Offering and Concurrent Private Placement of Common Stock, Warrants
-
NXT-ID Announces $3,432,000 Registered Direct Offering and Concurrent Private Placement
-
BeiGene, Ltd. (BGNE) PT Raised to $73 at Maxim Group; Positive on Celgene Deal
-
Seanergy Maritime Holdings Corp. Reports Financial Results for the Quarter Ended March 31, 2017
-
Prima BioMed (PBMD) Announces Pricing of $5M Registered Direct Offering of ADSs
-
Prima BioMed Announces Pricing of US$5.0 Million Registered Direct Offering of Its American Depositary Shares
-
Seanergy Maritime Holdings Corp. Announces Termination of its "At-The-Market" Equity Offering Program
-
Michael Frankel Joins HilltopSecurities’ Capital Markets
-
Maxim Group Starts Good Times Restaurants (GTIM) at Buy
-
Maxim Group Starts Del Taco Restaurants (TACO) at Buy
-
Interpace Diagnostics Announces Closing of $13.7 Million Public Offering
-
Maxim Group Reiterates Hold on Chipotle Mexican Grill (CMG)
-
UPDATE: Maxim Group Upgrades Pluristem Therapeutics (PSTI) to Buy
-
Apple (AAPL) PT Raised to $180 at Maxim Group, Raises FY18 EPS Estimate To Street High
-
UPDATE: Maxim Group Downgrades Wayfair (W) to Hold
-
Interpace Diagnostics (IDXG) Prices 12.5M Share Common Offering at $1.10/Sh
-
Interpace Diagnostics Announces Pricing of $13.7 Million Underwritten Public Offering of Common Stock and Common Warrants
-
Viking Therapeutics (VKTX) Enters $4.3M Registered Direct Offering
-
Viking Therapeutics Announces $4.3 Million Registered Direct Offering
-
Maxim Group Upgrades Cheesecake Factory (CAKE) to Buy
-
Maxim Group Reiterates Buy on Omeros (OMER) Following Announced Therapy Designation for OMS721
-
Maxim Group Reiterates Buy Rating & $4 PT on Trovagene (TROV); 'AstraZeneca (AZN) On Board to Use Trovera'
-
MagneGas (MNGA) Receives $25M from Convertible Preferred Financing
-
MagneGas Announces $25 Million Convertible Preferred Financing
-
Maxim Group Downgrades SciClone Pharmaceuticals (SCLN) to Hold
-
Inolife Technologies Announces Non-Brokered Private Placement
-
Maxim Group Starts Tecogen (TGEN) at Buy
-
Maxim Group Starts Sensus Healthcare (SRTS) at Buy
-
Sonoma Pharmaceuticals (SNOA) PT Raised to $10 at Maxim Group Following 4Q
-
Complimentary Transcript Available for Product Tanker Webinar
-
Maxim Group Upgrades bluebird bio (BLUE) to Buy Ahead of ASCO Presentation
-
Inolife Technologies Inc. (OTC: INOL) Engages Investment Banking Firm the Maxim Group LLC

